Natpara and Dyspnea exacerbated - a phase IV clinical study of FDA data
Summary:
Dyspnea exacerbated is reported as a side effect among people who take Natpara (parathyroid hormone), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Calcium, and have Hypoparathyroidism.
The phase IV clinical study analyzes which people have Dyspnea exacerbated when taking Natpara. It is created by eHealthMe based on reports of 4,485 people who have side effects when taking Natpara from the FDA, and is updated regularly.
What is Natpara?
Natpara has active ingredients of parathyroid hormone. eHealthMe is studying from 4,488 Natpara users. Check the latest studies of Natpara.
What is Dyspnea exacerbated?
Dyspnea exacerbated is found to be associated with 3,320 drugs and 1,659 conditions by eHealthMe. Check the latest studies of Dyspnea exacerbated.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
4,485 people reported to have side effects when taking Natpara.
Among them, 89 people (1.98%) have Dyspnea exacerbated.

Among these 89 people:
How long have people been on Natpara when they have Dyspnea exacerbated? *
- < 1 month: 42.86 %
- 1 - 6 months: 57.14 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Dyspnea exacerbated when taking Natpara? *
- female: 93.9 %
- male: 6.1 %
What is the age of people who have Dyspnea exacerbated when taking Natpara? *
- 0-1: 1.72 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 5.17 %
- 30-39: 12.07 %
- 40-49: 12.07 %
- 50-59: 24.14 %
- 60+: 44.83 %
What are other drugs people take besides Natpara? *
- Calcium: 33 people, 37.08%
- Magnesium: 24 people, 26.97%
- Omeprazole: 14 people, 15.73%
- Cymbalta: 13 people, 14.61%
- Calcitriol: 13 people, 14.61%
- Methocarbamol: 13 people, 14.61%
- Candesartan Cilexetil: 13 people, 14.61%
- Torsemide: 13 people, 14.61%
- Levothyroxine Sodium: 9 people, 10.11%
- Synthroid: 3 people, 3.37%
What are other side effects people have besides Dyspnea exacerbated? *
- Blood Calcium Decreased: 19 people, 21.35%
- Hypocalcaemia (levels of calcium in blood serum are abnormally low): 16 people, 17.98%
- Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 13 people, 14.61%
- Nausea (feeling of having an urge to vomit): 13 people, 14.61%
- Weakness: 12 people, 13.48%
- Fatigue (feeling of tiredness): 11 people, 12.36%
- Chest Pain: 11 people, 12.36%
- Heart Palpitations (feelings or sensations that your heart is pounding or racing): 10 people, 11.24%
- Hypoaesthesia (reduced sense of touch or sensation): 9 people, 10.11%
- Feeling Abnormal: 9 people, 10.11%
What are the existing conditions these people have? *
- Hypoparathyroidism (inadequate secretion of parathyroid hormone resulting in abnormally low levels of calcium in the blood): 60 people, 67.42%
- High Blood Pressure: 14 people, 15.73%
- Oedema (fluid collection in tissue): 14 people, 15.73%
- Pain: 10 people, 11.24%
- Fibromyalgia (a long-term condition which causes pain all over the body): 8 people, 8.99%
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 8 people, 8.99%
- Hypocalcaemia (levels of calcium in blood serum are abnormally low): 5 people, 5.62%
- Papillary Thyroid Cancer: 3 people, 3.37%
- Hyperparathyroidism (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium): 3 people, 3.37%
- Migraine (headache): 2 people, 2.25%
* Approximation only. Some reports may have incomplete information.
Do you take Natpara and have Dyspnea exacerbated?
- Check whether Dyspnea exacerbated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Natpara:
- Natpara (4,488 reports)
Dyspnea exacerbated treatments and more:
- Dyspnea exacerbated (2,061 reports)
How severe was Dyspnea exacerbated and when was it recovered:
Expand to all the drugs that have ingredients of parathyroid hormone:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Natpara:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Dyspnea exacerbated:
- Dyspnea exacerbated (3,320 drugs)
Browse all the conditions that are associated with Dyspnea exacerbated:
- Dyspnea exacerbated (1,659 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on parathyroid hormone (the active ingredients of Natpara) and Natpara (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Januvia vs. Avandaryl, side effect and effectiveness comparison - 5 seconds ago
- Marijuana vs. Flurazepam Hydrochloride, side effect and effectiveness comparison - 7 seconds ago
- Could Cellcept cause Constipation? - 35 seconds ago
- Ortho Evra and Depakote drug interactions for women aged 30-39 - 46 seconds ago
- Albuterol and Lung Neoplasm for Women aged 40-49 - 55 seconds ago
- Vitamin D and Famciclovir drug interactions for men aged 60+ - a minute ago
- Could Nplate cause Septic Shock? - a minute ago
- Could Nph Insulin cause Neck Pain? - a minute ago
- Could Novolog Mix 70/30 cause Fatigue? - a minute ago
- Could Piroxicam cause Heart Rate Irregular? - a minute ago